Benzinga | Nov 20, 2020 06:40AM EST

Cantor Fitzgerald Initiates Coverage On Ocuphire Pharma with Overweight Rating, Announces Price Target of $15

Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Ocuphire Pharma (NASDAQ:OCUP) with a Overweight rating and announces Price Target of $15.